MARKET

ACIU

ACIU

AC Immune
NASDAQ
2.700
-0.190
-6.57%
After Hours: 2.720 +0.02 +0.74% 17:14 03/27 EDT
OPEN
2.850
PREV CLOSE
2.890
HIGH
2.920
LOW
2.700
VOLUME
260.56K
TURNOVER
--
52 WEEK HIGH
4.000
52 WEEK LOW
1.430
MARKET CAP
274.79M
P/E (TTM)
-3.0644
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ACIU last week (0316-0320)?
Weekly Report · 6d ago
AC Immune FY 2025 Results: Eyeing ACI-7104 Catalysts
Seeking Alpha · 03/21 12:25
AC Immune SA COO Piergiorgio Donati files initial beneficial ownership statement
Reuters · 03/20 15:59
BRIEF-AC Immune Presents First In Vivo Images Of Brain Tdp-43 Pathology From Phase 1 Trial Of Pet Tracer Aci-19626, At Ad/Pdtm 2026
Reuters · 03/19 12:08
AC Immune’s PET tracer shows efficacy detecting brain pathologies
TipRanks · 03/19 11:41
AC Immune reports Phase 1 in vivo brain imaging data for TDP-43 PET tracer ACI-19626
Reuters · 03/19 11:00
AC Immune SA CFO Christopher James Roberts files initial beneficial ownership statement
Reuters · 03/18 17:09
AC Immune SA Director Monika Buetler Files Initial Beneficial Ownership Statement
Reuters · 03/18 16:36
More
About ACIU
AC Immune SA is a Switzerland-based clinical-stage biopharmaceutical company. The Company focuses on precision medicine for neurodegenerative diseases. It designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen and Morphomer technology platforms to create antibodies, small molecules and vaccines designed to address a broad range of neurodegenerative indications, such as Alzheimer's disease (AD). The Company's pipeline includes nine therapeutic product candidates with five in clinical trials, and three diagnostic candidates. Its lead product candidate is Crenezumab, a humanized and monoclonal anti-Abeta antibody for Alzheimer’s disease. It has collaborations with pharmaceutical companies, including Roche/Genentech, Eli Lilly, Biogen, Janssen Pharmaceuticals, Nestle Institute of Health Sciences, Life Molecular Imaging (formerly Piramal Imaging) and Essex Bio-Technology.

Webull offers AC Immune SA stock information, including NASDAQ: ACIU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACIU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACIU stock methods without spending real money on the virtual paper trading platform.